120 related articles for article (PubMed ID: 1932746)
1. Molecular basis for antithrombin III type I deficiency: three novel mutations located in exon IV.
Vidaud D; Emmerich J; Sirieix ME; Sié P; Alhenc-Gelas M; Aiach M
Blood; 1991 Nov; 78(9):2305-9. PubMed ID: 1932746
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI.
Gandrille S; Vidaud D; Emmerich J; Clauser E; Sié P; Fiessinger JN; Alhenc-Gelas M; Priollet P; Aiach M
Br J Haematol; 1991 Jul; 78(3):414-20. PubMed ID: 1873224
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6.
Emmerich J; Chadeuf G; Alhenc-Gelas M; Gouault-Heilman M; Toulon P; Fiessinger JN; Aiach M
Thromb Haemost; 1994 Oct; 72(4):534-9. PubMed ID: 7878627
[TBL] [Abstract][Full Text] [Related]
4. Recurrent deletion in the human antithrombin III gene.
Grundy CB; Thomas F; Millar DS; Krawczak M; Melissari E; Lindo V; Moffat E; Kakkar VV; Cooper DN
Blood; 1991 Aug; 78(4):1027-32. PubMed ID: 1868237
[TBL] [Abstract][Full Text] [Related]
5. Novel point mutations leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ; Lane DA; Ireland H; Leone G; De Stefano V; Wiesel ML; Cazenave JP; Thein SL
Br J Haematol; 1991 Jul; 78(3):408-13. PubMed ID: 1873223
[TBL] [Abstract][Full Text] [Related]
6. A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ; Lane DA; Finazzi G; Barbui T; Thein SL
Blood; 1990 Dec; 76(11):2182-6. PubMed ID: 1979501
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin III Kumamoto: identification of a point mutation and genotype analysis of the family.
Ueyama H; Murakami T; Nishiguchi S; Maeda S; Hashimoto Y; Okajima K; Shimada K; Araki S
Thromb Haemost; 1990 Apr; 63(2):231-4. PubMed ID: 2194315
[TBL] [Abstract][Full Text] [Related]
8. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
[TBL] [Abstract][Full Text] [Related]
9. Partial deletion of an antithrombin III allele in a kindred with a type 1 deficiency.
Fernandez-Rachubinski F; Rachubinski RA; Blajchman MA
Blood; 1992 Sep; 80(6):1476-85. PubMed ID: 1520874
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
Molho-Sabatier P; Aiach M; Gaillard I; Fiessinger JN; Fischer AM; Chadeuf G; Clauser E
J Clin Invest; 1989 Oct; 84(4):1236-42. PubMed ID: 2794060
[TBL] [Abstract][Full Text] [Related]
11. Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity.
Blajchman MA; Fernandez-Rachubinski F; Sheffield WP; Austin RC; Schulman S
Blood; 1992 Mar; 79(6):1428-34. PubMed ID: 1547341
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.
Tamura S; Hashimoto E; Suzuki N; Kakihara M; Odaira K; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Suzuki A; Okamoto S; Kanematsu T; Matsushita T; Kojima T
Thromb Res; 2019 Jun; 178():159-170. PubMed ID: 31030036
[TBL] [Abstract][Full Text] [Related]
13. Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene.
Picard V; Bura A; Emmerich J; Alhenc-Gelas M; Biron C; Houbouyan-Reveillard LL; Molho P; Labatide-Alanore A; Sié P; Toulon P; Verdy E; Aiach M
Br J Haematol; 2000 Sep; 110(3):731-4. PubMed ID: 10997988
[TBL] [Abstract][Full Text] [Related]
14. CpG dinucleotides are "hotspots" for mutation in the antithrombin III gene. Twelve variants identified using the polymerase chain reaction.
Perry DJ; Carrell RW
Mol Biol Med; 1989 Jun; 6(3):239-43. PubMed ID: 2615648
[TBL] [Abstract][Full Text] [Related]
15. Two case reports of inherited antithrombin deficiency: a novel frameshift mutation and a large deletion including all seven exons detected using two methods.
Sekiya A; Morishita E; Karato M; Maruyama K; Shimogawara I; Omote M; Wakugawa Y; Shinohara M; Hayashi T; Kadohira Y; Asakura H; Nakao S; Ohtake S
Int J Hematol; 2011 Feb; 93(2):216-219. PubMed ID: 21240680
[TBL] [Abstract][Full Text] [Related]
16. Type I antithrombin deficiency: five novel mutations associated with thrombosis.
Daly M; Perry DJ; Bruce DB; Harper PL; Tait RC; Walker ID; Mayne EE; Daly HM; Brown K; Carrell RW
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):139-43. PubMed ID: 8735803
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis.
Jochmans K; Lissens W; Vervoort R; Peeters S; De Waele M; Liebaers I
Blood; 1994 Jan; 83(1):146-51. PubMed ID: 8274732
[TBL] [Abstract][Full Text] [Related]
18. Six missense mutations associated with type I and type II protein C deficiency and implications obtained from molecular modelling.
Zheng YZ; Sakata T; Matsusue T; Umeyama H; Kato H; Miyata T
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):687-96. PubMed ID: 7865674
[TBL] [Abstract][Full Text] [Related]
19. Detection of two novel mutations (nt2762, exon 2, CAG to TAG, and nt2483 or 2484, exon 2, +A) in individuals with congenital type I antithrombin deficiencies.
Nakahara Y; Tsuji H; Nakagawa K; Masuda H; Kitamura H; Nishimura H; Kasahara T; Sugano T; Sawada S; Sakata T; Miyata T; Inoue N; Nakagawa M
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):229-31. PubMed ID: 10456612
[TBL] [Abstract][Full Text] [Related]
20. Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing.
Olds RJ; Lane DA; Caso R; Girolami A; Thein SL
Nucleic Acids Res; 1990 Apr; 18(7):1926. PubMed ID: 2336381
[No Abstract] [Full Text] [Related]
[Next] [New Search]
